WeightlessRx vs Hims
A factual side-by-side of the two programs across medication, pricing, support, and clinical care.
At a glance
| Feature | WeightlessRx | Hims |
|---|---|---|
| Medications offered | Compounded semaglutide, compounded tirzepatide | Compounded semaglutide; oral options |
| Membership fee | None | $69/month |
| Included GLP-1 fitness app | Yes | No |
| 1-on-1 nutrition coaching | Included | Add-on or limited |
| Direct clinician messaging | Unlimited | Available |
| Personalized meal plans | Included | Limited |
| HSA / FSA eligible | Yes | Yes |
| Free shipping | Yes | Yes |
Medication
Both programs offer compounded semaglutide. WeightlessRx also offers compounded tirzepatide for members who want stronger results or have plateaued. Hims primarily focuses on semaglutide and oral options through its weight-loss vertical.
Pricing structure
WeightlessRx charges only for medication — no separate membership. Hims layers a $69/month membership on top of medication cost. Across a 12-month treatment course, the membership difference adds up to roughly $828.
Support and coaching
WeightlessRx includes a GLP-1 fitness app, on-demand workouts, personalized meal plans, and 1-on-1 nutrition coaching at no extra cost. Hims provides clinician messaging but coaching and fitness are more limited or available as add-ons.
Who each is best for
- WeightlessRx — members who want a single all-in subscription with medication, coaching, and fitness, and who may want the option to upgrade to tirzepatide.
- Hims — existing Hims customers managing multiple men’s-health needs on one platform.
Frequently asked questions
Is the medication itself different between WeightlessRx and Hims?
Can I switch from Hims to WeightlessRx?
Ready when you are.
Take a 90-second medical intake. Your clinician reviews it and prescribes only when clinically appropriate.
See treatment plans →Related reading
Editorial standards & medical oversight
This educational content follows WeightlessRx clinical content standards and is reviewed for accuracy against current obesity-medicine and GLP-1 treatment guidelines, including FDA prescribing information, the American Association of Clinical Endocrinology (AACE) obesity guideline, and peer-reviewed clinical literature. Information is educational and is not medical advice. Treatment eligibility is determined only after a U.S.-licensed clinician in our third-party provider network reviews your intake and medical history. Read our full medical review policy →